首页> 外文期刊>Brazilian Journal of Medical and Biological Research >Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease
【24h】

Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease

机译:血清层粘连蛋白,IV型胶原和透明质酸是非酒精性脂肪肝疾病中纤维化的标志物

获取原文
获取外文期刊封面目录资料

摘要

Hepatic fibrosis in patients with non-alcoholic fatty liver disease is associated with progression of the disease. In the present study, we analyzed the discriminative ability of serum laminin, type IV collagen and hyaluronan levels to predict the presence of fibrosis in these patients. In this preliminary report, we studied 30 overweight patients divided into two groups according to the absence (group I, N = 19) or presence (group II, N = 11) of fibrosis in a liver biopsy. Triglycerides, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltranspeptidade, hyaluronan (noncompetitive fluoroassay), type IV collagen, and laminin (ELISA) were determined. Group II presented significantly higher mean laminin, hyaluronan, type IV collagen, and aspartate aminotransferase values, which were due to the correlation between these parameters and the stage of fibrosis in the biopsy (Spearman's correlation coefficient, rS = 0.65, 0.62, 0.53, and 0.49, respectively). Analysis of the ROC curve showed that laminin values >282 ng/ml were those with the best diagnostic performance, with 87% accuracy. Association of laminin with type IV collagen showed improvement in the positive predictive value (100%), but with reduction in diagnostic sensitivity (64%). When compared with the criteria of Ratziu et al. [Gastroenterology (2000) 118: 1117-1123] for the diagnosis of septal fibrosis, laminin values presented a better diagnostic accuracy (83 vs 70%). Determination of extracellular matrix components in serum, especially of laminin, may identify patients with non-alcoholic fatty liver disease and fibrosis and these components may be used as indicators for liver biopsy in these patients.
机译:非酒精性脂肪肝患者的肝纤维化与疾病进展有关。在本研究中,我们分析了血清层粘连蛋白,IV型胶原蛋白和透明质酸水平的判别能力,以预测这些患者中纤维化的存在。在这份初步报告中,我们研究了30名超重患者,根据肝活检中是否存在纤维化(I组,N = 19)或存在(II组,N = 11)分为两组。测定了甘油三酸酯,天冬氨酸转氨酶,丙氨酸转氨酶,γ-谷氨酰转肽酶,透明质酸(非竞争性荧光测定法),IV型胶原蛋白和层粘连蛋白(ELISA)。第II组的平均层粘连蛋白,透明质酸,IV型胶原和天冬氨酸转氨酶值显着较高,这是由于这些参数与活检中纤维化阶段之间的相关性(Spearman相关系数,rS = 0.65、0.62、0.53和分别为0.49)。 ROC曲线分析表明,层粘连蛋白值> 282 ng / ml是诊断性能最好的那些,准确度为87%。层粘连蛋白与IV型胶原的结合显示出阳性预测值有所改善(100%),但诊断敏感性降低(64%)。当与Ratziu等人的标准进行比较时。 [Gastroenterology(2000)118:1117-1123]用于间隔纤维化的诊断,层粘连蛋白值具有更好的诊断准确性(83%对70%)。测定血清中的细胞外基质成分,尤其是层粘连蛋白,可以确定患有非酒精性脂肪肝和纤维化的患者,这些成分可以用作这些患者肝活检的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号